Clinical Trial

Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

Study acronym: SPHINX
Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to assess the efficacy of a partially hydrolyzed formula with synbiotics in halting one of the first steps of the allergic march (atopic dermatitis) in infants at risk of allergy. Other efficacy and safety parameters will be assessed as well.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-16; most recent amendment 2025-12-11.
Status change: Not Yet Recruiting → Recruiting 2025-05-12
Trial Details
NCT Number NCT06943469
Lead Sponsor Société des Produits Nestlé (SPN)
Conditions Atopic Dermatitis (AD)
Enrollment 400 participants
Start Date 2025-04-10
Primary Completion 2027-10 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-30